Skip to main content

Table 2 Patient characteristics

From: Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker

Characteristics

No. of Pts (N = 73)

%

Sex

  

   Male

48

65.8

   Female

25

34.2

Age, years

  

   median

59

 

   range

24–77

 

Performance status

  

   ECOG 0–1

60

82.2

   ECOG 2

13

17.8

Histopathologic type

  

   Intestinal type

47

64.4

   Diffuse type

23

31.5

   Unknown

3

4.1

Disease status

  

   Relapsed

19

26.0

   Initial stage IV

54

74.0

Metastatic site

  

   Liver

30

41.1

   Peritoneum

29

39.7

   LN (distant M1 node)

23

31.5

   Others

18

24.7

  1. ECOG, eastern cooperative oncology group; LN, lymph node.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us